Laboratoire de Virologie, Institut des Agents Infectieux, Groupement Hospitalier Nord, Hospices Civils de Lyon, Lyon, France; University of Lyon, Université Lyon 1, CIRI, Inserm U1111 CNRS UMR5308, Virpath, Lyon, France.
Aix Marseille University, IRD, AP-HM, MEPHI, IHU Méditerranée Infection, Marseille, France.
Clin Microbiol Infect. 2020 Jul;26(7):947.e1-947.e4. doi: 10.1016/j.cmi.2020.03.010. Epub 2020 Mar 20.
We aimed to describe bacterial co-infections and acute respiratory distress (ARDS) outcomes according to influenza type and subtype.
A retrospective observational study was conducted from 2012 to 2016 in patients admitted to the respiratory intensive care unit (ICU) of Marseille university hospital for influenza-induced ARDS. Microbiological investigations, including multiplex molecular respiratory panel testing and conventional bacteriological cultures, were performed as part of the routine ICU care on the bronchoalveloar lavage collected at admission. Bacterial co-infections, ICU mortality and respiratory function were investigated according to virus type and subtype.
Among the 45 ARDS patients included, A(H1N1)pdm09 was the most frequent influenza virus identified (28/45 A(H1N1)pdm09, eight out of 45 A(H3N2) and nine out of 45 influenza B). Bacterial co-infections involving a total of 23 bacteria were diagnosed in 16/45 patients (36%). A(H1N1)pdm09 patients presented fewer bacterial co-infections (17.9% vs. 50.0% for A(H3N2) patients and 77.8% for B patients; p < 0.01). Overall, mortality at 90 days post admission was 33.3% (15/45), and there was no significant difference between influenza type and subtype. The need for extracorporeal membrane oxygenation was more frequent for A(H1N1)pdm2009 (20/28, 71.4%) and B patients (7/9, 77.8%) than the A(H3N2) subtype (1/8, 12.5%; p < 0.01). A(H1N1)pdm09-ARDS patients were associated with fewer ventilation-free days at day 28 (median (IQR): 0 (0-8) days) compared with other influenza-ARDS patients (15 (0-25) days, p < 0.05).
In a population of influenza-induced ARDS, A(H1N1)pdm09 was associated with fewer bacterial co-infections but poorer respiratory outcomes. These data underline the major role of A(H1N1)pdm09 subtype on influenza disease severity.
根据流感类型和亚型,描述细菌合并感染和急性呼吸窘迫综合征(ARDS)的结局。
这是一项回顾性观察性研究,2012 年至 2016 年期间,在马赛大学医院呼吸重症监护病房(ICU)因流感引起的 ARDS 而入院的患者中进行。作为常规 ICU 护理的一部分,对入院时采集的支气管肺泡灌洗液进行了微生物学检测,包括多重分子呼吸道检测面板和常规细菌培养。根据病毒类型和亚型,调查了细菌合并感染、ICU 死亡率和呼吸功能。
在 45 例 ARDS 患者中,A(H1N1)pdm09 是最常见的流感病毒(28/45 例 A(H1N1)pdm09、8/45 例 A(H3N2)和 9/45 例 B 型流感)。在 45 例患者中诊断出 16 例(36%)合并细菌感染,涉及 23 种细菌。A(H1N1)pdm09 患者的细菌合并感染较少(17.9%比 A(H3N2)患者的 50.0%和 B 型患者的 77.8%;p<0.01)。总的来说,入院后 90 天的死亡率为 33.3%(15/45),流感类型和亚型之间没有显著差异。与 A(H3N2)亚型(1/8,12.5%)相比,A(H1N1)pdm2009(20/28,71.4%)和 B 型(7/9,77.8%)患者更需要体外膜肺氧合(ECMO)(p<0.01)。与其他流感相关性 ARDS 患者(28 天无通气天数中位数(IQR):15(0-25)天)相比,A(H1N1)pdm09-ARDS 患者的无通气天数较少(0(0-8)天)(p<0.05)。
在流感相关性 ARDS 患者中,A(H1N1)pdm09 与较少的细菌合并感染但较差的呼吸结局相关。这些数据强调了 A(H1N1)pdm09 亚型在流感疾病严重程度中的主要作用。